Does closure of a patent foramen ovale have a role in the treatment of migraine with aura?

Neurological Sciences

Volumn 29, Issue SUPPL. 1, 2008, Pages

  D'Amico, Domenico ^a   Usai, Susanna ^a   Caputi, Luigi ^a   Bussone, Gennaro ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Ischaemic stroke; Migraine with aura (MA); Patent foramen ovale (PFO); Percutaneous closure

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; ESTROGEN; FLUNARIZINE; GESTAGEN; LAMOTRIGINE; PLACEBO; TOPIRAMATE; VALPROIC ACID;

ANALGESIC ACTIVITY; ARTICLE; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; CLINICAL TRIAL; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; HEART ATRIUM FIBRILLATION; HEART SURGERY; HEART TAMPONADE; HUMAN; LOW DRUG DOSE; LUNG EMBOLISM; MIGRAINE WITH AURA; PATENT FORAMEN OVALE; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PROPHYLAXIS; REMISSION; RETROPERITONEAL HEMATOMA; RISK FACTOR; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

FORAMEN OVALE, PATENT; HUMANS; MIGRAINE WITH AURA;

EID: 45249122239     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-008-0880-y     Document Type: Article

References (64)

1. Henrich JB, Horwitz RI (1989) A controlled study of ischemic stroke risk in migraine patients. J Clin Epidemiol 42:773-780
2. Tzourio C, Iglesias S, Hubert JB et al (1993) Migraine and risk of ischaemic stroke: A case-control study. Br Med J 307:289-292
3. Marini C, Carolei A, Roberts RS et al (1993) Focal cerebral ischemia in young adults: A collaborative case-control study. The National Research Council Study Group. Neuroepidemiology 12:70-81
4. Tzourio C, Tehindrazanarivelo A, Iglesias S et al (1995) Casecontrol study of migraine and risk of ischaemic stroke in young women. Br Med J 310:830-833
5. Carolei A, Marini C, De Matteis G (1996) History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in the Young. Lancet 347:1503-1506
6. Chang CL, Donaghy M, Poulter N, The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception (1999) Migraine and stroke in young women: Case-control study. Br Med J 318:13-18
7. Donaghy M, Chang CL, Poulter N (2002) Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry 73:747-750
8. Etminan M, Takkouche B, Isorna FC, Samii A (2005) Risk of ischaemic stroke in people with migraine: Systematic review and meta-analysis of observational studies. Br Med J 330:63
9. Kurth T, Slomke MA, Kase CS et al (2005) Migraine, headache, and the risk of stroke in women: A prospective study. Neurology 64:1020-1102
10. Stang PE, Carson AP, Rose KM et al (2005) Headache, cerebrovascular symptoms, and stroke: The Atherosclerosis Risk in Communities Study. Neurology 64:1573-1577
11. Becker C, Brobert GP, Almqvist PM et al (2007) Migraine and the risk of stroke, TIA, or death in the UK (CME). Headache 47:1374-1384
12. Overell JR, Bone I, Less KR (2000) Interatrial septal abnormalities and stroke. A meta-analysis of case-control studies. Neurology 55:1172-1179
13. Amarenco P (2005) Patent foramen ovale and the risk of stroke: Smoking gun guilty by association? Heart 91:441-443
14. Handke M, Harloff A, Olschewski M et al (2007) Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 357:2262-2268
15. Homma S, Sacco RL, DiTullio MR et al for PICSS Investigators (2202) Effect of medical treatment in stroke patients with patent foramen ovale. Circulation 105:2625-2631
16. Del Sette M, Angeli S, Leandri M et al (1998) Migraine with aura and right-to-left shunt on transcranial Doppler: A case-control study. Cerebrovasc Dis 8:327-330
17. Anzola GP, Magoni M, Guindani M et al (1999) Potential source of cerebral embolism in migraine with aura: A transcranial Doppler study. Neurology 52:1622-1625
18. Wilmshurst P, Nightingale S. Walsh KP, Morrison WL (2000) Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 356:1648-1651
19. Dalla Volta G, Guindani M, Zavarise P et al (2005) Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype. J Headache Pain 6:328-330
20. Schwerzmann M, Nedeltchev K, Lagger F et al (2005) Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 65:1415-1418
21. Carod-Artal FJ, da Silveira Ribeiro L, Braga H et al (2006) Prevalence of patent foramen ovale in migraine patients with and without aura compared with stroke patients. A transcranial Doppler study. Cephalalgia 26:934-939
22. Domitrz I, Mieszkowski J, Kaminska A (2007) Relationship between migraine and patent foramen ovale: A study of 121 patients with migraine. Headache 47:1311-1318
23. Anzola GP, Meneghetti G, Zanferrari C et al; the SaM Study Group (2008) Is migraine associated with right-to-left shunt a separate disease? Results of the SAM study. Cephalalgia 28:360-366
24. Morandi E, Anzola GP, Angeli S et al (2003) Transcatheter closure of patent foramen ovale: A new migraine treatment? J Interv Cardiol 16:39-42
25. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL (2000) Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 356:1648-1651
26. Schwerzmann M, Wiher S, Nedeltchev K et al (2004) Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 62:1399-1401
27. Post M, Thijs V, Herroelen L, Budts W (2004) Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 62:1439-1440
28. Reisman M, Christofferson RD, Jesurum J et al (2005) Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 45:493-495
29. Azarbal B, Tobis J, Suh W et al (2005) Association of interatrial shunts and migraine headaches: Impact of transcatheter closure. J Am Coll Cardiol 45:489-492
30. Giardini A, Donti A, Formigari R et al (2006) Long-term efficacy of transcatheter patent foramen ovale closure on migraine headache with aura and recurrent stroke. Catheter Cardiovasc Interv 67:625-629
31. Anzola GP, Frisoni GB, Morandi E et al (2006) Shunt-associated migraine response favorably to atrial septal repair: A case-control study. Stroke 37:430-434
32. Dowson A, Mullen MJ, Peatfield R et al (2008) Migraine Intervention With STARFlex Technology (MIST) trial: A prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 117:1397-1404
33. Dubiel M, Bruch L, Schmehl I et al (2008) Migraine headache relief after percutaneous transcatheter closure of interatrial communications. J Interv Cardiol 21:32-37
34. Jesurum JT, Fuller CJ, Velez CA et al (2007) Migraineurs with patent foramen ovale have larger right-to-left shunt despite similar atrial septal characteristics. J Headache Pain 8:209-216
35. Giardini A, Donti A, Formigari R et al (2006) Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting. Am Heart J 151:922-925
36. Anzola GP, Morandi E, Casilli F, Onorato E (2006) Different degrees of right-to-left shunting predict migraine and stroke: Data from 420 patients. Neurology 66:765-767
37. Meissner I, Khandheira BK, Heit JA et al (2006) Patent foramen ovale; innocent or guilty? J Am Coll Cardiol 47:440-445
38. Di Tullio MR, Sacco RL, Sciacca RR et al (2007) Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol 49:797-802
39. Mas JL, Arquizan C, Lamy C et al (2001) Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 345:1740-1746
40. De Castro S, Cartoni D, Fiorelli M et al (2000) Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 31:2407-2413
41. Kimmelstiel C, Gange C, Thaler D (2007) Is patent foramen ovale closure effective in reducing migraine symptoms? A controlled study. Catheter Cardiovasc Interv 69:740-746
42. Buring JE, Peto R, Hennekens CH (1990) Low-dose aspirin for migraine prophylaxis. JAMA 264:1711-1713
43. Diener HC, Hartung E, Chrubasik J et al (2001) A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, doubleblind, parallel group phase III study. Cephalalgia 21:120-128
44. Bensenor IM, Cook NR, Lee IM et al (2001) Low-dose aspirin for migraine prophylaxis in women. Cephalalgia 21:175-183
45. Sharifi M, Burks J (2004) Efficacy of clopidogrel in the treatment of post-ASD closure migraines. Catheter Cardiovasc Interv 63:255
46. Cologno D, Torelli P, Cademartiri C, Manzoni GC (2000) A prospective study of migraine with aura attacks in a headache clinic population. Cephalalgia 20:925-930
47. Silberstein SD for the US Headache Consortium (2000) Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55:754-762
48. Evers S, Afra J, Frese A, Goadsby PJ et al (2006) EFNS guideline on the drug treatment of migraine-report of an EFNS task force. Eur J Neurol 13:560-572
49. D'Andrea G, Granella F, Cadaldini M, Manzoni GC (1999) Effectiveness of lamotrigine in the prophylaxis of migraine with aura: An open pilot study. Cephalalgia 19:64-66
50. Pascual J, Caminero AB, Mateos V et al (2004) Preventing disturbing migraine aura with lamotrigine: An open study. Headache 44:1024-1028
51. Lampl C, Katsarava Z, Diener HC, Limmroth V (2005) Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry 76:1730-1732
52. De Simone R, Marano E, Di Stasio E et al (2005) Acetazolamide efficacy and tolerability in migraine with aura: A pilot study. Headache 45:385-386
53. SPREAD-Stroke Prevention And Educational Awareness Diffusion (2007) Ictus cerebrale: Linee Guida Italiane, V edn. 20 December
54. Khairy P, O'Donnell C, Landzberg MJ (2003) Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli. A systematic review. Ann Intern Med 139:753-760
55. Anzola GP, Morandi E, Casilli F, Onorato E (2004) Does transcatheter closure of patent foramen ovale really "shut the door": A prospective study with transcranial Doppler. Stroke 35:2140-2144
56. Egred M, Andron M, Albouaini K et al (2007) Percutaneous closure of patent foramen ovale and atrial septal defect: Procedure outcome and medium-term follow-up. J Interv Cardiol 20:395-401
57. Wahl A, Kunz M, Moscovitis A et al (2008) Long-term results after fluoroscopy guided closure of patent foramen ovale for secondary prevention of paradoxical embolism. Heart 94:336-341
58. Bousser MG (2004) Estrogens, migraine, and stroke. Stroke 35[11 Suppl 1]:2652-2656
59. D'Amico D, Moschiano F, Leone M et al (1998) Genetic abnormalities of the protein C system: Shared risk factors in young adults with migraine with aura and with ischemic stroke? Cephalalgia 18:618-621
60. Giardini A, Donti A, Formigari R et al (2007) Spontaneous large right-to-left shunt and migraine headache with aura are risk factors for recurrent stroke in patients with a patent foramen ovale. Int J Cardiol 120:357-362
61. D'Amico D, Moschiano F, Attanasio A et al (2003) Hyperhomocysteinemia in patients with migraine with aura. Cephalalgia 23:742
62. Kowa H, Yasui K, Takeshima T et al (2000) The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 96:762-764
63. Pezzini A, Grassi M, Del Zotto E et al (2007) Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect. Stroke 38:3145-3151
64. Diener HC, Kurth T, Dodick D (2007) Patent foramen ovale, stroke, and cardiovascular disease in migraine. Curr Opin Neurol 20:310-319